Amsterdam UMC, VU University Medical Center, Department of Public and Occupational Health, Amsterdam Public Health research institute, Van der Boechorststraat 7, 1081BT, Amsterdam, The Netherlands.
Department of Public and Occupational Health, Amsterdam UMC location Vrije Universiteit Amsterdam, De Boelelaan 1117, Amsterdam, The Netherlands.
Trials. 2023 Feb 17;24(1):114. doi: 10.1186/s13063-022-06960-z.
A healthy lifestyle is indispensable for the prevention of noncommunicable diseases. However, lifestyle medicine is hampered by time constraints and competing priorities of treating physicians. A dedicated lifestyle front office (LFO) in secondary/tertiary care may provide an important contribution to optimize patient-centred lifestyle care and connect to lifestyle initiatives from the community. The LOFIT study aims to gain insight into the (cost-)effectiveness of the LFO.
Two parallel pragmatic randomized controlled trials will be conducted for (cardio)vascular disorders (i.e. (at risk of) (cardio)vascular disease, diabetes) and musculoskeletal disorders (i.e. osteoarthritis, hip or knee prosthesis). Patients from three outpatient clinics in the Netherlands will be invited to participate in the study. Inclusion criteria are body mass index (BMI) ≥25 (kg/m) and/or smoking. Participants will be randomly allocated to either the intervention group or a usual care control group. In total, we aim to include 552 patients, 276 in each trial divided over both treatment arms. Patients allocated to the intervention group will participate in a face-to-face motivational interviewing (MI) coaching session with a so-called lifestyle broker. The patient will be supported and guided towards suitable community-based lifestyle initiatives. A network communication platform will be used to communicate between the lifestyle broker, patient, referred community-based lifestyle initiative and/or other relevant stakeholders (e.g. general practitioner). The primary outcome measure is the adapted Fuster-BEWAT, a composite health risk and lifestyle score consisting of resting systolic and diastolic blood pressure, objectively measured physical activity and sitting time, BMI, fruit and vegetable consumption and smoking behaviour. Secondary outcomes include cardiometabolic markers, anthropometrics, health behaviours, psychological factors, patient-reported outcome measures (PROMs), cost-effectiveness measures and a mixed-method process evaluation. Data collection will be conducted at baseline, 3, 6, 9 and 12 months follow-up.
This study will gain insight into the (cost-)effectiveness of a novel care model in which patients under treatment in secondary or tertiary care are referred to community-based lifestyle initiatives to change their lifestyle.
ISRCTN ISRCTN13046877 . Registered 21 April 2022.
健康的生活方式对于预防非传染性疾病是不可或缺的。然而，生活方式医学受到时间限制和治疗医生优先事项竞争的阻碍。在二级/三级保健中设立一个专门的生活方式前台办公室（LFO）可能会对优化以患者为中心的生活方式护理以及与社区的生活方式倡议建立联系做出重要贡献。LFOFIT 研究旨在深入了解 LFO 的（成本）效益。
将针对心血管疾病（即（有风险的）心血管疾病、糖尿病）和肌肉骨骼疾病（即骨关节炎、髋关节或膝关节假体）进行两项平行的实用随机对照试验。将邀请荷兰三个门诊诊所的患者参加这项研究。纳入标准为体重指数（BMI）≥25（kg/m）和/或吸烟。参与者将被随机分配到干预组或常规护理对照组。我们总共计划纳入 552 名患者，每个试验各 276 名，分为两个治疗组。分配到干预组的患者将参加与所谓的生活方式经纪人的面对面动机访谈（MI）辅导课程。患者将得到支持和指导，以参与适合社区的生活方式倡议。将使用网络通信平台在生活方式经纪人、患者、转介的社区生活方式倡议和/或其他相关利益相关者（例如全科医生）之间进行沟通。主要结局指标是改良的 Fuster-BEWAT，这是一个复合健康风险和生活方式评分，由静息收缩压和舒张压、客观测量的体力活动和久坐时间、BMI、水果和蔬菜摄入量以及吸烟行为组成。次要结局包括心血管代谢标志物、人体测量学、健康行为、心理因素、患者报告的结局测量（PROM）、成本效益测量和混合方法的过程评估。数据将在基线、3、6、9 和 12 个月随访时收集。
这项研究将深入了解一种新型护理模式的（成本）效益，该模式将接受二级或三级护理的患者转介到社区生活方式倡议中，以改变他们的生活方式。
ISRCTN ISRCTN84222035。于 2022 年 4 月 21 日注册。
